Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis

Volumn 16, Issue , 2000, Pages 280-284

  Mars, R L ^a   Moles, K ^a   Pope, K ^a   Hargrove, P ^a  

^a UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; GENTAMICIN; TOBRAMYCIN;

ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FEMALE; HUMAN; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONITIS; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION;

ANTI-BACTERIAL AGENTS; FEMALE; GENTAMICINS; HUMANS; MALE; MIDDLE AGED; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS; TOBRAMYCIN;

EID: 0033655943     PISSN: 11978554     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)